Certified by Founder Lodge
INCE Capital
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $50,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
INCE Capital is a venture capital firm with an investment focus on early to expansion stage companies that spearhead innovation in the Internet consumer and intelligent technologies sectors.
| Company | Date | Round | Raised |
|---|---|---|---|
 Allorion Therapeutics |
March, 13 ,2023 | Series B | $50,000,000 |
 LunarCrush |
July, 13 ,2023 | Series A | $5,000,000 |
 Bubblemaps |
September, 19 ,2023 | Seed | $3,200,000 |
 Avenzo Therapeutics |
September, 23 ,2025 | Series B | $60,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
IORGANBIO | $2,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
